logo

Biodistribution and pharmacokinetics of 99mTc-CQDO and 99mTc-CQDO-MeB for new myocardial imaging agent

Biodistribution and pharmacokinetics of 99mTc-CQDO and 99mTc-CQDO-MeB for new myocardial imaging agent

ZHU Junqing
LUO Shineng
WU Chunying
JI Shuren
CAO Guoxian
ZHOU Xiang
CHENG Zhengping
MO Yiqing
Nuclear Science and TechniquesVol.10, No.4pp.217-220Published in print 01 Nov 1999
25100

A comparison of 99mTc- CQDO and 99mTc-CQDO-MeB has been made for biodistribution and pharmacokinetics. 99mTc-CQDO and its adducts of methaneboronic acid 99mTc-CQDO-MeB were prepared by the reduction of Na99mTcO4 with SnCl2·2H2O in aqueous solution. Radiochemical purity of 99mTc-CQDO and 99mTc-CQDO-MeB determined by TLC were over 95% after extraction. Biodistri-butions of 99mTc-CQDO and 99mTc-CQDO-MeB in mice demonstrated that both of them could be easily absorbed by myocardium, and the peak uptake of each were 10.83±2.2% ID/g and 11.84±1.69%ID/g, respectively. 99mTc-CQDO showed rapid clearance from myocardial tissue while 99mTc-CQDO-MeB had long retention in heart muscle. The myocardial uptake of 99mTc-CQDO was only 5.88±1.66%ID/g at 10min. and the uptake of 99mTc-CQDO-MeB was 7.42±0.17%ID/g at 60 min. The elimination of each from blood has a biexponential pattern, the first T1/2 is 1.38 and 1.5 min, respectively. The partition coefficient of 99mTc-CQDO and 99mTc-CQDO-MeB were 20 and 25 at pH 7.40, respectively.

BiodistributionPharmacokinetics99mTc-CQDO99mTc-CQDO-MeB
References
1 Numm A D, Feld T A, Trher E N.

Boronic acid adducts of technetium-99m dioxime complexes

. U S Patent 4705849, 1987
Baidu ScholarGoogle Scholar
2 Milena J, Henzlova , Machac J. J Nucl Med. 1994, 35: 575
3 Luo S N, Xie M H, Xi Y F et al. Nucl Tech, 1993, 16(11): 687
4 Wang F, Yang Y F, Qian Z H et al. Nucl Tech, 1996, 19(5): 265